CDK inhibitors from past to present: A new wave of cancer therapy
Author:
Funder
Fundo para o Desenvolvimento das Ciências e da Tecnologia
Publisher
Elsevier BV
Subject
Cancer Research
Reference125 articles.
1. Cell cycle proteins as promising targets in cancer therapy;Otto;Nat. Rev. Cancer,2017
2. Cell cycle, CDKs and cancer: a changing paradigm;Malumbres;Nat. Rev. Cancer,2009
3. Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis;Gavet;Dev. Cell,2010
4. New insights into cyclins, CDKs, and cell cycle control;Sánchez,2005
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent contributions of pyridazine as a privileged scaffold of anticancer agents in medicinal chemistry: An updated review;Bioorganic & Medicinal Chemistry;2024-09
2. Posttranslational modifications of E2F family members in the physiological state and in cancer: Roles, mechanisms and therapeutic targets;Biomedicine & Pharmacotherapy;2024-09
3. Cell morphology and gene expression: tracking changes and complementarity across time and cell lines;2024-09-01
4. Discovery of Sesquiterpene Lactones with Cytotoxicity from the Herb of Youngia japonica;Chemistry & Biodiversity;2024-08-16
5. The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions;European Journal of Drug Metabolism and Pharmacokinetics;2024-08-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3